Y40 Adverse effects in therapeutic use, systemic antibiotics

Add Analogs Compare

Medications used: More... hide

Pharm. gr.	Substance	Drugs
Antidiarrheal microorganisms	Bacillus subtilis
	Bifidobacterium bifidum	Bifidumbacterin \| Бифидумбактерин сухой
	Lactobacillus acidophilus	Yogulact 55+ \| Yogulact forte \| Lactonorm
Antifungal agents	Ketoconazole	Ketoconazole
Hepatoprotectors	Ademetionine	Heparetta
Other immunomodulators	Echinaceae purpurae herbae succus	Immunal
	Oxyethylammonium methylphenoxiacetate
	Treonyl-glutamyl-lysyl-lysyl-glutamyl-arginyl-arginyl-glutamyl-treonyl-valyl-glutamyl-arginyl-glutamyl-lysyl-glutamate	Hepon
Other immunomodulators in combinations	Ascorbic acid+Echinaceae herbae succus	Immunal plus C
Regenerants and reparants in combinations	Multivitamins
Vitamins and vitamin-like products in combinations	Multivitamins+Minerals	Bio-Max \| Lavita

Tree of ICD-10 diagnoses

Y40 Adverse effects in therapeutic use, systemic antibiotics (Selected ICD-10 diagnosis)
Subsections:
Y40.7 Adverse effects in therapeutic use, antifungal antibiotics, systemically used
Y40.9 Adverse effects in therapeutic use, systemic antibiotic, unspecified
✚ Y41 Adverse effects in therapeutic use, other systemic anti-infectives and antiparasitics
✚ Y42 Adverse effects, hormones and their synthetic substitutes and antagonists, not elsewhere classified
✚ Y43 Adverse effects in therapeutic use, primarily systemic agents
✚ Y44 Adverse effects in therapeutic use, agents primarily affecting blood constituents
✚ Y45 Adverse effects in therapeutic use, analgesics, antipyretics and anti-inflammatory drugs
Y46 Adverse effects in therapeutic use, antiepileptics and antiparkinsonism drugs
✚ Y47 Adverse effects in therapeutic use, sedatives, hypnotics and antianxiety drugs
✚ Y48 Adverse effects in therapeutic use, anaesthetics and therapeutic gases
✚ Y49 Adverse effects in therapeutic use, psychotropic drugs, not elsewhere classified
✚ Y51 Adverse effects in therapeutic use, drugs primarily affecting the autonomic nervous system
✚ Y52 Adverse effects in therapeutic use, agents primarily affecting the cardiovascular system
✚ Y53 Adverse effects in therapeutic use, agents primarily affecting the gastrointestinal system
✚ Y54 Adverse effects in therapeutic use, agents primarily affecting water-balance and mineral and uric acid metabolism
✚ Y55 Adverse effects in therapeutic use, agents primarily acting on smooth and skeletal muscles and the respiratory system
✚ Y56 Adverse effects in therapeutic use, topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
✚ Y57 Adverse effects in therapeutic use, other and unspecified drugs and medicaments

Description

There is no detailed description, see related

Related diseases

✘Available only when using PRO account

Content moderator: Vasin A. S.